Patterson Matthew R 4
4 · Vor Biopharma Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
Patterson Matthew R
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-26+30,000→ 30,000 totalExercise: $4.79Exp: 2033-05-25→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 26, 2024 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.